Abstract
The perinatal period is a time of substantial bone mass accrual with many factors affecting long-term bone mineralization. Currently it is unclear what effect maternal gestational/type 2 diabetes has on infant bone mass accrual. This is a prospective study of offspring of Native American and Hispanic mothers with normoglycemia (n = 94) and gestational diabetes or type 2 diabetes (n = 64). Infant anthropometrics were measured at birth, 1, and 6 months of age. Cord blood leptin, high-molecular weight adiponectin (HMWA), pigment epithelium-derived factor (PEDF), vascular epithelium growth factor (VEGF), endoglin, and C-peptide were measured by ELISA. Infants had bone mineral density measurement at 1 month or/and 6 months of age using dual-energy x-ray absorptiometry scan. Mothers with diabetes were older (31 ± 6 years vs 25 ± 4 years) and had higher pre-pregnancy BMI (32.6 ± 5.8 vs 27.2 ± 6.4 kg/m2) than control mothers. Mean HbA1C of mothers with diabetes was 5.9 ± 1.0% compared to 5.1 ± 0.3% in controls early in pregnancy. Infants born to mothers with diabetes (DM-O) were born at a slightly lower gestational age compared to infants born to control mothers (Con-O). There was no difference in total body less head bone mineral content (BMC) or bone mineral density (BMD) between DM-O and Con-O. For both groups together, bone area, BMD, and BMC tracked over the first 6 months of life (r: 0.56, 0.38, and 0.48, respectively). Percent fat was strongly and positively correlated with BMC at 1 month of age (r = 0.44; p < 0.001) and BMC at both 1 and 6 months of age correlated strongly with birth weight. There were no associations between infant bone mass and cord blood leptin, PEDF, or VEGF, while C-peptide had a significant correlation with BMC at 1 and 6 months only in DM-O (p = 0.01 and 0.03, respectively). Infants born to mothers with well-controlled gestational/type 2 diabetes have normal bone mass accrual. Bone mineral content during this time is highly correlated with indices of infant growth and the association of bone mineral indices with percent body fat suggests that bone-fat crosstalk is operative early in life.
Similar content being viewed by others
References
Ryan S (1998) Bone mineralization in preterm infants. Nutrition 14(10):745–747
Dennison EM, Cooper C, Cole ZA (2010) Early development and osteoporosis and bone health. J Dev Orig Health Dis 1(3):142–149
Harvey N, Dennison E, Cooper C (2014) Osteoporosis: a lifecourse approach. J Bone Miner Res 29(9):1917–1925
Yang Y, Wu F, Dwyer T, Antony B, Winzenberg T, Jones G (2020) Associations of breastfeeding, maternal smoking, and birth weight with bone density and microarchitecture in young adulthood: a 25-year birth-cohort study. J Bone Miner Res 35(9):1652–1659
Sudhagoni RG, Wey HE, Djira GD, Specker BL (2012) Longitudinal effects of fat and lean mass on bone accrual in infants. Bone 50(3):638–642
Seeman E (1994) Reduced bone density in women with fractures: contribution of low peak bone density and rapid bone loss. Osteoporos Int 4(Suppl 1):15–25
Damm P, Houshmand-Oeregaard A, Kelstrup L, Lauenborg J, Mathiesen ER, Clausen TD (2016) Gestational diabetes mellitus and long-term consequences for mother and offspring: a view from Denmark. Diabetologia 59(7):1396–1399
Chen J, Yang X, Huang L, Zhang Z, Yao J, Liang H et al (2021) Insulin resistance biomarkers in small-for-gestational-age infants born to mothers with gestational diabetes mellitus. J Mater-Fetal & Neonatal Med. https://doi.org/10.1080/14767058.2021.2014449
Gou BH, Guan HM, Bi YX, Ding BJ (2019) Gestational diabetes: weight gain during pregnancy and its relationship to pregnancy outcomes. Chin Med J (Engl) 132(2):154–160
Minton SD, Steichen JJ, Tsang RC (1983) Decreased bone mineral content in small-for-gestational-age infants compared with appropriate-for-gestational-age infants: normal serum 25-hydroxyvitamin D and decreasing parathyroid hormone. Pediatrics 71(3):383–388
Mughal MZ, Ross R, Tsang RC (1989) Clearance of calcium across in situ perfused placentas of intrauterine growth-retarded rat fetuses. Pediatr Res 25(4):420–422
Namgung R, Tsang RC (2000) Factors affecting newborn bone mineral content: in utero effects on newborn bone mineralization. Proceedings of the Nutrition Society 59(1):55–63
Littner Y, Mandel D, Mimouni FB, Dollberg S (2004) Decreased bone ultrasound velocity in large-for-gestational-age infants. J Perinatol 24(1):21–23
Mimouni F, Steichen JJ, Tsang RC, Hertzberg V, Miodovnik M (1988) Decreased bone mineral content in infants of diabetic mothers. Am J Perinatol 5(4):339–343
Lapillonne A, Guerin S, Braillon P, Claris O, Delmas PD, Salle BL (1997) Diabetes during pregnancy does not alter whole body bone mineral content in infants. J Clin Endocrinol Metab 82(12):3993–3997
Schushan-Eisen I, Cohen M, Leibovitch L, Maayan-Metzger A, Strauss T (2015) Bone density among infants of gestational diabetic mothers and macrosomic neonates. Matern Child Health J 19(3):578–582
Regev RH, Dolfin T, Eliakim A, Arnon S, Bauer S, Nemet D et al (2004) Bone speed of sound in infants of mothers with gestational diabetes mellitus. J Pediatr Endocrinol Metab 17(8):1083–1088
Guarnotta V, Mineo MI, Giacchetto E, Imbergamo MP, Giordano C (2021) Maternal-foetal complications in pregnancy: a retrospective comparison between type 1 and type 2 diabetes mellitus. BMC Pregnancy Childbirth 21(1):243
Belinsky GS, Sreekumar B, Andrejecsk JW, Saltzman WM, Gong J, Herzog RI et al (2016) Pigment epithelium-derived factor restoration increases bone mass and improves bone plasticity in a model of osteogenesis imperfecta type VI via Wnt3a blockade. FASEB J 30(8):2837–2848
Upadhyay J, Farr OM, Mantzoros CS (2015) The role of leptin in regulating bone metabolism. Metabolism 64(1):105–113
Malekzadeh B, Erlandsson MC, Tengvall P, Palmquist A, Ransjo M, Bokarewa MI et al (2018) Effects of implant-delivered insulin on bone formation in osteoporotic rats. J Biomed Mater Res A 106(9):2472–2480
Hu K, Olsen BR (2016) The roles of vascular endothelial growth factor in bone repair and regeneration. Bone 91:30–38
Teague AM, Fields DA, Aston CE, Short KR, Lyons TJ, Chernausek SD (2015) Cord blood adipokines, neonatal anthropometrics and postnatal growth in offspring of Hispanic and Native American women with diabetes mellitus. Reprod Biol Endocrinol 13:68
ACOG Practice Bulletin No (2018) 190: gestational diabetes mellitus. Obstet Gynecol 131(2):49–64
Venkataraman PS, Ahluwalia BW (1992) Total bone mineral content and body composition by x-ray densitometry in newborns. Pediatrics 90(5):767–770
Yarbrough DE, Barrett-Connor E, Morton DJ (2000) Birth weight as a predictor of adult bone mass in postmenopausal women: the Rancho Bernardo Study. Osteoporos Int 11(7):626–630
Martinez-Mesa J, Menezes AM, Howe LD, Wehrmeister FC, Muniz LC, Gonzalez-Chica DA et al (2014) Lifecourse relationship between maternal smoking during pregnancy, birth weight, contemporaneous anthropometric measurements and bone mass at 18years old. The 1993 Pelotas Birth Cohort. Early Human Devel 90(12):901–906
Kirk B, Feehan J, Lombardi G, Duque G (2020) Muscle, bone, and fat crosstalk: the biological role of myokines, osteokines, and adipokines. Curr Osteoporos Rep 18(4):388–400
Wang Y, Zhang X, Shao J, Liu H, Liu X, Luo E (2017) Adiponectin regulates BMSC osteogenic differentiation and osteogenesis through the Wnt/β-catenin pathway. Sci Rep 7(1):3652
Kanazawa I (2017) Interaction between bone and glucose metabolism [Review]. Endocr J 64(11):1043–1053
Reid IR, Baldock PA, Cornish J (2018) Effects of Leptin on the Skeleton. Endocr Rev 39(6):938–959
Cock TA, Auwerx J (2003) Leptin: cutting the fat off the bone. Lancet 362(9395):1572–1574
Javaid MK, Godfrey KM, Taylor P, Robinson SM, Crozier SR, Dennison EM et al (2005) Umbilical cord leptin predicts neonatal bone mass. Calcif Tissue Int 76(5):341–347
Akcakus M, Kurtoglu S, Koklu E, Kula M, Koklu S (2007) The relationship between birth weight leptin and bone mineral status in newborn infants. Neonatology 91(2):101–106
Schubring C, Siebler T, Kratzsch J, Englaro P, Blum WF, Triep K et al (1999) Leptin serum concentrations in healthy neonates within the first week of life: relation to insulin and growth hormone levels, skinfold thickness, body mass index and weight. Clin Endocrinol (Oxf) 51(2):199–204
Fulzele K, Clemens TL (2012) Novel functions for insulin in bone. Bone 50(2):452–456
Acknowledgements
We wish to thank study coordinators Mary Ayn Tullier, Justin Fowler, Olufolake Olufowote, and Shelly Hopper; the Choctaw Nation of Oklahoma, and the Chickasaw Nation and our study participants and families. This study was supported by NIH Grants R01 DK089034-03 (S. Chernausek, PI) and P20 MD000528-05 (T.Lyons, project PI); American Diabetes Association and Oklahoma Shared Clinical and Translational Resources (U54GM104938) with an Institutional Development Award (IDeA) from NIGMS (C. Aston). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors Sowmya Krishnan, Christopher E. Aston, David A. Fields, April M. Teague, Timothy J. Lyons and Steven D. Chernausek have no conflicts of interest to declare.
Ethical Approval
Signed informed consent was obtained from a parent of each infant in accordance with the University of Oklahoma Health Sciences Center, Chickasaw Nation and/or Choctaw Nation of Oklahoma institutional review boards, each of which approved the study. All clinical investigations have been conducted according to the principles expressed in the Declaration of Helsinki.
Informed Consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Krishnan, S., Aston, C.E., Fields, D.A. et al. Bone Mass Accrual in First Six Months of Life: Impact of Maternal Diabetes, Infant Adiposity, and Cord Blood Adipokines. Calcif Tissue Int 111, 248–255 (2022). https://doi.org/10.1007/s00223-022-00990-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00223-022-00990-0